{"resourceType":"CodeSystem","id":"substance-grade","meta":{"lastUpdated":"2022-05-28T13:47:40.239+11:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n            <p>This code system http://hl7.org/fhir/substance-grade defines the following codes:</p>\n            <table class=\"codes\">\n              <tr>\n                <td style=\"white-space:nowrap\">\n                  <b>Code</b>\n                </td>\n                <td>\n                  <b>Display</b>\n                </td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">USP-NF\n                  <a name=\"substance-grade-USP-NF\"> </a>\n                </td>\n                <td>USP/NF United States Pharmacopeia (USP) and the National Formulary (NF)</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">Ph.Eur\n                  <a name=\"substance-grade-Ph.46Eur\"> </a>\n                </td>\n                <td>European Pharmacopoeia</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">JP\n                  <a name=\"substance-grade-JP\"> </a>\n                </td>\n                <td>Japanese Pharmacopoeia</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">BP\n                  <a name=\"substance-grade-BP\"> </a>\n                </td>\n                <td>British Pharmacopoeia</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">CompanyStandard\n                  <a name=\"substance-grade-CompanyStandard\"> </a>\n                </td>\n                <td>Company Standard</td>\n              </tr>\n            </table>\n          </div>"},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"brr"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status","valueCode":"trial-use"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":1}],"url":"http://hl7.org/fhir/substance-grade","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.4.642.1.1609"}],"version":"4.3.0","name":"SubstanceGrade","title":"SubstanceGrade","status":"draft","experimental":false,"date":"2021-01-05T10:01:24+11:00","publisher":"HL7 (FHIR Project)","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/fhir"},{"system":"email","value":"fhir@lists.hl7.org"}]}],"caseSensitive":true,"valueSet":"http://hl7.org/fhir/ValueSet/substance-grade","content":"complete","concept":[{"code":"USP-NF","display":"USP/NF United States Pharmacopeia (USP) and the National Formulary (NF)"},{"code":"Ph.Eur","display":"European Pharmacopoeia"},{"code":"JP","display":"Japanese Pharmacopoeia"},{"code":"BP","display":"British Pharmacopoeia"},{"code":"CompanyStandard","display":"Company Standard"}]}